Pharmaceuticals · PSX stock comparison

Searle (SEARL) vs GlaxoSmithKline (GLAXO)

The Searle Company Limited and GlaxoSmithKline Pakistan Limited: compare valuation, dividends and financial performance side by side.

SEARL ↗

The Searle Company Limited

Rs 79.18

PSX snapshot · 18/11/2026, 18:41:00 PKT

GLAXO ↗

GlaxoSmithKline Pakistan Limited

Rs 333.13

PSX snapshot · 18/11/2026, 18:41:00 PKT

Some annual figures are withheld pending current reporting-year verification.

Gross and net marginsROE and ROAInventory and liquidity
Searle (SEARL) vs GlaxoSmithKline (GLAXO): share price, valuation and financial ratios
MetricSEARLGLAXO
Market & valuationPSX quotes; issuer filings and dated SCSTrade fundamentals
Share priceRs 79.18Rs 333.13
P/E (TTM)11.98×9.66×
Annual dividend yield—5.10%FY 2025
Annual dividend per share—Rs 17.00FY 2025
Price / book (calculated)1.31×2027 Q13.08×2026 Q2
Market capRs 46.58BRs 106.09B
1-year price change · excluding payouts-24.70%-14.20%
Profitability & financial healthIssuer filings / SCSTrade · period and source shown per figure
Book value per shareRs 60.422027 Q1Rs 108.122026 Q2
Return on equity (ROE)—29.77%2025 Q4
Return on assets (ROA)—19.78%2025 Q4
Gross profit margin—37.00%2025 Q4
Net profit margin—15.21%2025 Q4
Inventory turnover—5.16×2025 Q4
Current ratio1.87×2027 Q12.28×2026 Q2
Quick ratio—1.48×2025 Q4

Sources & reporting periods

Prices and trailing P/E: PSX DPS. Annual yield = full-year cash dividend divided by displayed PSX price. Annual dividends and financial ratios: reviewed issuer filings and SCSTrade. Financial year and dividend/share are shown for both stocks; unclear feed yields are excluded. Price/book uses reported book value. PSX 1-year price changes exclude payouts; they are not total returns. Reviewed issuer ratios use unconsolidated statements and labelled year-end denominators. Unverified borrowing ratios are omitted.

More pharmaceuticals comparisons

Pharmaceuticals

Pharmaceutical companies: compare profitability, returns and working capital.